Metabolism and Lack of DNA Reactivity of the Mycotoxin Ochratoxin A in Cultured Rat and Human Primary Hepatocytes
- 18 January 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 50 (4) , 938-945
- https://doi.org/10.1021/jf0111817
Abstract
It is still unclear whether the carcinogenic mycotoxin ochratoxin A (OTA) is bioactivated to DNA-binding metabolites in rodents and humans. Therefore, we have incubated cultured rat and human primary hepatocytes with noncytotoxic concentrations of 3H-OTA ranging from 10-7 to 10-5 M for 8 h and determined its metabolism and covalent DNA binding. In rat hepatocytes, OTA was metabolized to small amounts of three products, which were further studied by electrospray ionization (ESI)−MS/MS techniques. In addition to 4-hydroxy-OTA, which is a known product of OTA biotransformation, two novel metabolites were detected and tentatively identified as hexose and pentose conjugates of OTA. The in vitro induction with 3-methylcholanthrene (3MC) increased the formation of 4-hydroxy-OTA but did not alter the formation of the conjugated metabolites. No covalent binding of 3H-OTA or its metabolites to DNA was observed in rat hepatocytes with or without 3MC induction with a limit of detection of 2 adducts per 109 nucleotides. However, the cellular ratio of reduced glutathione to oxidized glutathione was significantly decreased by treatment with OTA. In cultured human hepatocytes, 3H-OTA was only very poorly metabolized, and no covalent DNA binding was observed. In conclusion, the results of this in vitro study do not support the notion that OTA has the potential to undergo metabolic activation and form covalent DNA adducts in rodents and humans. Keywords: Ochratoxin A; metabolism; covalent DNA binding; hepatocytes; humanKeywords
This publication has 31 references indexed in Scilit:
- Application of liquid chromatography-atmospheric pressure ionization mass spectrometry in natural product analysis evaluation and optimization of electrospray and heated nebulizer interfacesPublished by Elsevier ,1998
- P XVI A.7: P XVI A.7 In vitro DNA and nucleotides adducts formation caused by ochratoxin AMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- Formation of ochratoxin a metabolites and DNA-adducts in monkey kidney cellsChemico-Biological Interactions, 1995
- Structure-activity studies in E. coli strains on ochratoxin A (OTA) and its analogues implicate a genotoxic free radical and a cytotoxic thiol derivative as reactive metabolites☆Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
- Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin AMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Role of ochratoxin in disease causationFood and Chemical Toxicology, 1992
- Characterization of pig liver purified cytochrome P-450 isoenzymes for ochratoxin a metabolism studiesToxicology Letters, 1991
- Induction of characteristic chromosomal aberrations, particularly X-trisomy, in cultured human lymphocytes treated by ochratoxin A, A mycotoxin implicated in Balkan endemic nephropathyMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Evaluation of ochratoxin A for mutagenicity in a battery of bacterial and mammalian cell assaysFood and Chemical Toxicology, 1985
- Genotoxicity of ochratoxin a in mice: DNA single-strand break evaluation in spleen, liver and kidneyToxicology Letters, 1985